WASHINGTON, Jan. 11 (UPI) -- The anticipated approval of a new dosing regimen for AstraZeneca's Symbicort in Europe could significantly alter the asthma drug market, analysts said Wednesday. The ...

AstraZeneca is developing new labelling for its combination asthma medication Symbicort that could boost its prospects against rival drug Seretide/Advair from GlaxoSmithKline, according to Datamonitor ...

AstraZeneca turned up the pressure in its head-to-head battle with GlaxoSmithKline in the asthma arena yesterday, after winning approval for a new dosing regimen for its combination product Symbicort.

The SMART (Symbicort Maintenance and Reliever Therapy) approach allows patients to increase the dose of Symbicort (a combination of an inhaled corticosteroid and long-acting bronchodilator) during ...

Viatris’ new drug-device is the first FDA-approved generic version of AstraZeneca’s Symbicort. Kindeva Drug Delivery, a contract development and manufacturing organization, and Viatris announced FDA ...

Budesonide, formoterol fumarate 80mcg/4.8mcg, 160mcg/4.8mcg; per inh; pressurized metered-dose inhaler. Store at controlled room temperature 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Symbicort Rapihaler contains two active ingredients in one inhaler: ...

(RTTNews) - The U.S. Food and Drug Administration approved Mylan Pharmaceuticals, Inc.'s generic of Symbicort (budesonide and formoterol fumarate dihydrate) inhalation aerosol. It is the first FDA- ...